NCT00294710View on ClinicalTrials.gov

A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine

PHASE3CompletedINTERVENTIONAL
Enrollment

976

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Hypertension
Interventions
DRUG

Aliskiren

Trial Locations (2)

07936

Novartis, East Hanover

Unknown

Investigative Centers

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00294710 - A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine | Biotech Hunter | Biotech Hunter